Evidence check: Progesteron in the context of Blutzucker

The relationship between progesterone and blood sugar is scientifically plausible but the evidence is mixed. Progesterone, especially at elevated levels during the luteal phase of the menstrual cycle or pregnancy, can reduce insulin sensitivity and slightly raise fasting glucose. Mechanistically, progesterone impairs glucose uptake in muscle and fat cells and increases hepatic glucose production. However, individual responses vary widely, and many studies show no significant effect on long-term glycemic markers like HbA1c. The strongest associations are seen in conditions like gestational diabetes or polycystic ovary syndrome (PCOS), where progesterone fluctuations interact with other hormonal imbalances. Importantly, progesterone alone is rarely the primary driver of chronic hyperglycemia; lifestyle, diet, and other hormones (estrogen, cortisol) are more influential. Consumer tests like those from MyBody-X may measure progesterone as part of a hormone panel, but they do not directly assess blood sugar regulation. The evidence is best described as 'mixed/unclear' – there are mechanistic and observational hints, but no robust clinical consensus for general recommendations.